Company Filing History:
Years Active: 2022-2025
Title: Udaya Rangaswamy: Innovator in Antibody Technology
Introduction
Udaya Rangaswamy is a prominent inventor based in Newark, CA (US). He has made significant contributions to the field of antibody technology, holding 2 patents that focus on innovative treatments for B cell disorders.
Latest Patents
His latest patents include "Heavy chain antibodies binding to CD19" and "Multispecific heavy chain antibodies with modified heavy chain constant regions." The first patent discloses anti-CD19 heavy chain antibodies, including methods of making such antibodies and their use in treating B cell disorders characterized by the expression of CD19. The second patent provides multispecific human heavy chain antibodies that have modified heavy chain constant regions, which impart advantageous properties. This invention also concerns methods of making these antibodies and their use in treating disorders characterized by the expression of one or more binding targets.
Career Highlights
Udaya Rangaswamy is associated with Teneotwo, Inc., where he continues to advance his research and development in antibody technology. His work has the potential to significantly impact the treatment of various B cell disorders.
Collaborations
Some of his notable coworkers include Katherine Harris and Nathan D Trinklein, who contribute to the innovative environment at Teneotwo, Inc.
Conclusion
Udaya Rangaswamy's contributions to antibody technology exemplify the innovative spirit of modern science. His patents reflect a commitment to developing effective treatments for serious medical conditions.